SCHEMBL9555614

SCHEMBL9555614

O=C1NC(=[Se])c2ccccc21

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 1/20 0.67
▸ CASP3 P42574 2/20 0.56
▸ CASP7 P55210 2/20 0.56
▸ CASP6 P55212 2/20 0.56
▸ CASP8 Q14790 2/20 0.56
▸ CASP2 P42575 1/20 0.56
▸ PDGFRA P16234 1/20 0.48
▸ FER P16591 1/20 0.48
▸ LTK P29376 1/20 0.48
▸ CDK8 P49336 1/20 0.48
▸ ACVR1 Q04771 1/20 0.48
▸ LRRK2 Q5S007 1/20 0.48
▸ DYRK1B Q9Y463 1/20 0.48
▸ LMNA P02545 4/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ MAPK1 P28482 3/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ TDP2 O95551 2/20 0.43
▸ CASP9 P55211 1/20 0.43
▸ MAP3K14 Q99558 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phthalimide SCHEMBL7771670 0.81 GSK3B (1.00) GSK3BCASP3CASP7CASP6CASP8
Phthalimide SCHEMBL10192661 0.81 GSK3B (1.00) GSK3BCASP3CASP7CASP6CASP8
Phthalimide SCHEMBL30125197 0.81 GSK3B (1.00) GSK3BCASP3CASP7CASP6CASP8
Phthalimide SCHEMBL29366030 0.81 GSK3B (1.00) GSK3BCASP3CASP7CASP6CASP8
Phthalimide SCHEMBL64 0.81 GSK3B (1.00) GSK3BCASP3CASP7CASP6CASP8
Phthalimide SCHEMBL11040503 0.81 GSK3B (1.00) GSK3BCASP3CASP7CASP6CASP8
Phthalimide SCHEMBL9561193 0.78 GSK3B (0.94) GSK3BCASP3CASP7CASP6CASP8
Phthalimide SCHEMBL7065407 0.78 GSK3B (0.94) GSK3BCASP3CASP7CASP6CASP8
Phthalimide SCHEMBL4948697 0.78 GSK3B (0.94) GSK3BCASP3CASP7CASP6CASP8
Phthalimide SCHEMBL7521027 0.78 GSK3B (0.94) GSK3BCASP3CASP7CASP6CASP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109232151-B Solid-phase synthesis method of 1, 1-diaryl alkene compound 云南大学 2021-08-17 — — CN claimed
CN-112851624-A Synthetic method of 2-benzoxazepine compound 云南大学 2021-05-28 — — CN claimed
EP-0349060-A2 Process for the formation of 6-desmethyl-6-exo-methylene derivatives of lovastatin and analogs thereof MERCK & CO. INC. (US) 1990-01-03 — — EP claimed
JP-5230021-A — — None — — JP disclosed
CN-114920684-B Selenium-containing benzamide compound and synthetic method and application thereof 浙江工业大学 2023-12-05 — — CN disclosed
CN-114736150-A off-DNA and on-DNA synthesis method of arylselenoindole compound 浙江工业大学 2022-07-12 — — CN disclosed
CN-109232151-B Solid-phase synthesis method of 1, 1-diaryl alkene compound 云南大学 2021-08-17 — — CN disclosed
JP-H05230021-A PRODUCTION OF INDOLE DERIVATIVE NIPPON STEEL CHEM CO LTD 1993-09-07 — — JP disclosed
EP-0349060-A2 Process for the formation of 6-desmethyl-6-exo-methylene derivatives of lovastatin and analogs thereof MERCK & CO. INC. (US) 1990-01-03 — — EP disclosed
US-4866186-A Process for the formation of 6-desmethyl-6-exo-methylene derivatives of lovastatin and analogs thereof MERCK & CO., INC. (US) 1989-09-12 — — US disclosed
Send feedback